Harsh R. Shah, DO

Harsh Shah DO is an Associate Professor of Medicine in the Division of Hematology at the Huntsman Cancer Center, University of Utah.

Dr. Shah’s clinical expertise is in the treatment of various lymphomas, such as Hodgkin’s Lymphoma, T-cell Lymphomas, DLBCL, Mantle Cell Lymphoma, Follicular Lymphoma, CLL, etc. He has a research interest in immunotherapy resistance pathways in the treatment of Hodgkin Lymphomas, particularly the role of Tumor Associated Macrophages. He is also interested in developing novel clinical trials for T cell lymphomas.

He completed his internal medicine training at Indiana University in Indianapolis and hematology and oncology fellowship at Karmanos Cancer Institute/Wayne State University in Detroit, Michigan. He is certified in both hematology and oncology.